HYOSCINE BUTYLBROMIDE INJECTION

Google image searchProduct monograph

Active ingredient

hyoscine butylbromide, 20 MG/ML

DIN: 02229868

Dosage form(s): SOLUTION

Route(s) of administration: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

Schedule: Prescription

Company: SANDOZ CANADA INCORPORATED

Date: 28-MAY-2007

ATC:

• A03 — DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS (ATC, ATC/DDD, )
• A03B — BELLADONNA AND DERIVATIVES, PLAIN (ATC, ATC/DDD)
• A03BB — Belladonna alkaloids, semisynthetic, quaternary ammonium compounds (ATC, ATC/DDD)
• A03BB01 — BUTYLSCOPOLAMINE (ATC/DDD)

Reference brand drug: Buscopan

Pharmaceutical standard: MFR

External Links for Hyoscine Butylbromide Injection

Search on Google

• Hyoscine Butylbromide Injection side effects
• Hyoscine Butylbromide Injection dosage
• hyoscine butylbromide side effects
• hyoscine butylbromide dosage

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find hyoscine butylbromide injection photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.